Nuoncology Labs Inc
OTC:NLAB
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | EV/FCFF | ||||
---|---|---|---|---|---|
US |
N
|
Nuoncology Labs Inc
OTC:NLAB
|
29.3B USD | -1 004 063.9 | |
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
486.5B CAD | -1 563 803.1 | |
US |
G
|
Gould Investors LP
OTC:GDVTZ
|
334.2B USD | 0 | |
US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | -1 592 000.2 | |
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
78.8B Zac | 0 | |
US |
Music Licensing Inc
OTC:SONG
|
64.3B USD | 570 593.3 | ||
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
902.9T IDR | 186.6 | ||
US |
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | ||
US |
Ergo Science Corp
OTC:ERGN
|
55.2B USD | -15 989.6 | ||
US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | -34 937.7 | |
US |
G
|
GE Vernova LLC
NYSE:GEV
|
48.2B USD | 0 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.